Alnylam Pharmaceuticals, Inc. (ALNY)
303.00
+1.89
(+0.63%)
USD |
NASDAQ |
May 06, 16:00
303.00
0.00 (0.00%)
After-Hours: 20:00
Alnylam Pharmaceuticals SG&A Expense (TTM) : 1.293B for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.56B |
| Pfizer Inc. | 10.76B |
| Aldeyra Therapeutics, Inc. | 9.602M |
| Ionis Pharmaceuticals, Inc. | 467.79M |
| Glaukos Corp. | 354.02M |